×
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis PDF
$ 40.00
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis PDF quantity
$ 40.00
×
Remission, Residual Symptoms, and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice. PDF
$ 40.00
Remission, Residual Symptoms, and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice. PDF quantity
$ 40.00
×
Impairment and Functioning in a Sample of Primary Care Patients With Generalized Anxiety Disorder: Results From the Primary Care Anxiety Project PDF
$ 40.00
Impairment and Functioning in a Sample of Primary Care Patients With Generalized Anxiety Disorder: Results From the Primary Care Anxiety Project PDF quantity
$ 40.00
×
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use PDF
$ 40.00
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use PDF quantity
$ 40.00
×
Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications PDF
$ 40.00
Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
